HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2005.058560v1 52/2/171    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (34) Citing Articles via Google Scholar Google Scholar Articles by Bossuyt, X. Search for Related Content PubMed PubMed Citation Articles by Bossuyt, X. Related Collections Clinical Immunology

Serologic Markers in Inflammatory Bowel Disease

¹ Laboratory Medicine, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Fax 32-16-347931; e-mail Xavier.Bossuyt{at}uz.kuleuven.ac.be.

Inflammatory bowel disease (IBD) is an enduring disease involving mostly young people, with symptoms of bloody diarrhea and abdominal cramps. Several antibodies have been associated with IBD, the 2 most comprehensively studied being autoantibodies to neutrophils (atypical perinuclear anti-neutrophil cytoplasmic antibodies) and anti-Saccharomyces cerevisiae antibodies. This review focuses on the value of these antibodies for diagnosing IBD, differentiating Crohn disease from ulcerative colitis, indeterminate colitis, monitoring disease, defining clinical phenotypes, predicting response to therapy, and as subclinical markers. Pancreatic antibodies and newly identified anti-microbial antibodies (anti-outer membrane porin C, anti-I2, and anti-flagellin) are also reviewed.

The following articles in journals at HighWire Press have cited this article:

				D Roggenbuck, G Hausdorf, L Martinez-Gamboa, D Reinhold, T Buttner, P R Jungblut, T Porstmann, M W Laass, J Henker, C Buning, et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease Gut, December 1, 2009; 58(12): 1620 - 1628. [Abstract] [Full Text] [PDF]

				C.-S. Chen, S. Sullivan, T. Anderson, A. C. Tan, P. J. Alex, S. R. Brant, C. Cuffari, T. M. Bayless, M. V. Talor, C. L. Burek, et al. Identification of Novel Serological Biomarkers for Inflammatory Bowel Disease Using Escherichia coli Proteome Chip Mol. Cell. Proteomics, August 1, 2009; 8(8): 1765 - 1776. [Abstract] [Full Text] [PDF]

				M. Papp, I. Altorjay, G. Lakos, J. Tumpek, S. Sipka, T. Dinya, K. Palatka, G. Veres, M. Udvardy, and P. L. Lakatos Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease Clin. Vaccine Immunol., April 1, 2009; 16(4): 464 - 470. [Abstract] [Full Text] [PDF]

				N. Vermeulen, I. Arijs, S. Joossens, S. Vermeire, S. Clerens, K. Van den Bergh, G. Michiels, L. Arckens, F. Schuit, L. Van Lommel, et al. Anti-{alpha}-enolase Antibodies in Patients with Inflammatory Bowel Disease Clin. Chem., March 1, 2008; 54(3): 534 - 541. [Abstract] [Full Text] [PDF]

				L. Henckaerts, M. Pierik, M. Joossens, M. Ferrante, P. Rutgeerts, and S. Vermeire Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease Gut, November 1, 2007; 56(11): 1536 - 1542. [Abstract] [Full Text] [PDF]

				M. Ferrante, L. Henckaerts, M. Joossens, M. Pierik, S. Joossens, N. Dotan, G. L Norman, R. T Altstock, K. Van Steen, P. Rutgeerts, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour Gut, October 1, 2007; 56(10): 1394 - 1403. [Abstract] [Full Text] [PDF]